This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Global Anticoagulants Industry

DVT Prevention in Surgery (includes corresponding

Graph/Chart) III-4

Payers Keen on New Therapies III-4

Pradaxa's Initial Performance Commendable, Conventional AVK

Products Still Dominate III-4

US Heparin Market III-5

Hinging on Market Opportunities III-5

Generics - Threatening Branded Anticoagulants III-5

List of Patent Protected Anticoagulants in the US III-6

Generic Competition Threatens Sanofi's Lovenox III-6

Table 26: Leading Players in the US Enoxaparin Sodium

Market (2011): Percentage Breakdown of Sales for Sandoz and

Sanofi (includes corresponding Graph/Chart) III-6

 

Table 27: US Enoxaparin Sodium Market by Sector (2011):

Percentage Breakdown of Sales for Institutional and Retail

Sectors (includes corresponding Graph/Chart) III-6

Ignorance - A Major Hindrance III-7

Future Challenges and Growth Drivers III-7

US Emerging Anticoagulant Market III-7

Product Introductions/Approvals III-8

Recent Industry Activity III-8

Focus on Select Players III-10

B.Market Analytics III-12

Table 28: US Recent Past, Current & Future Analysis for

Anticoagulants by Product Segment - Oral Anticoagulants and

Injectable Anticoagulants (Unfractionated Heparin and Low

Molecular Weight Heparin) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2010

through 2018 (includes corresponding Graph/Chart) III-12

 

Table 29: US Historic Review for Anticoagulants by Product

Segment - Oral Anticoagulants and Injectable Anticoagulants

(Unfractionated Heparin and Low Molecular Weight Heparin)

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-13

 

Table 30: US 15-Year Perspective for Anticoagulants by

Product Segment - Percentage Breakdown of Dollar Sales for

Oral Anticoagulants and Injectable Anticoagulants

(Unfractionated Heparin and Low Molecular Weight Heparin)

Markets for the Years 2004, 2011 & 2018 (includes

corresponding Graph/Chart) III-14

 

2. JAPAN III-15

A.Market Analysis III-15

Outlook III-15

Anticoagulants Market in Japan III-15

Rising Incidence of Pulmonary Thromboembolism III-15

Product Introductions/Approvals III-15

Recent Industry Activity III-16

Focus on Select Players III-16

9 of 15

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,828.24 +0.49 0.00%
S&P 500 2,067.56 -5.27 -0.25%
NASDAQ 4,791.63 +4.3130 0.09%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs